HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Oropharyngeal Cancer

Oropharyngeal Cancer

Oropharyngeal cancer, a type of head and neck cancer, primarily affects the back of the throat, tonsils, and base of the tongue. Research in this field focuses on various aspects such as identifying risk factors like tobacco and alcohol use, as well as human papillomavirus (HPV) infection. Understanding the molecular mechanisms underlying the development and progression of oropharyngeal cancer is crucial for developing targeted therapies. Immunotherapy, particularly checkpoint inhibitors, has shown promise in treating advanced cases by boosting the body's immune response against cancer cells. Early detection methods like HPV testing and imaging techniques play a vital role in improving patient outcomes. Additionally, ongoing studies explore the role of genetic predisposition and the tumor microenvironment in shaping the disease's behavior, paving the way for personalized treatment approaches.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp